We demonstrated that miR-497 plays a role in modulating the malignant phenotype and chemosensitivity of pancreatic cancer cells by directly inhibition of FGF2 and FGFR1 expression. This evidence concerns the gene FGF2 and familial pancreatic carcinoma.